South Africa’s Competition Tribunal has reportedly approved of the Nestle-Pfizer Nutrition baby formula merger, but with hard-hitting conditions, according to reports. Nestle and Pfizer stand as the largest and third-largest infant formula market in the country. The approval’s catch, however, requires a large divestment from Pfizer of its infant milk formula business, as the Tribunal found that the merger would leave only Aspen as a top competitor in the market. The Tribunal has included a list of concessions the parties need to address before the merger goes through. According to reports, remedies that have been suggested are similar to the remedies used to approve of the same deal in Australia; under the terms, Pfizer would reportedly divest its infant milk formula business in South Africa, and its new owner would rebrand the company and its products.
Featured News
Trump’s Defamation Case Against New York Times Advances in Federal Court
Nov 19, 2026 by
CPI
Musk’s xAI Faces Skeptical US Judges Over California AI Disclosure Law
Nov 19, 2026 by
CPI
Italy Ends Vorwerk Antitrust Probe After Consumer Compensation Deal
Nov 19, 2026 by
CPI
Canada Wins Court Order to Advance Gap, Old Navy Advertising Probe
Nov 19, 2026 by
CPI
Russia Orders Major Retailers to Disclose Food Pricing Data in Antitrust Review
Nov 19, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Labor Market Collusion
Nov 19, 2026 by
CPI
From Price-Fixing to Wage-Fixing: Are Labor Markets the Next Frontier of Public and Private Competition Law Enforcement?
Nov 19, 2026 by
Giulia Rurali & Carsten Krüger
Damage Estimation and Labor Market Collusion
Nov 19, 2026 by
Louis D. Pape
Recent Developments of Labor Market Collusion in the EU: The Dialogue Between Delivery Hero and Tondela
Nov 19, 2026 by
Catarina Vieira Peres & Rita Ferreira Gomes
Enforcement in Labor Collusion and Monopsony: Trends and Challenges
Nov 19, 2026 by
Leyla Karakas & Anna Meyendorff